Daniel Maldonado
Bis 2018, Director Country Operations, Chiltern International Ltd
Mexico City, Mexiko
Werdegang
Berufserfahrung von Daniel Maldonado
Bis heute 6 Jahre, seit Juni 2018
Founder
Revol CRC
2 Jahre und 5 Monate, Jan. 2016 - Mai 2018
Director Country Operations
Chiltern International Ltd
1 Jahr, Feb. 2015 - Jan. 2016
Assoc Manager Clinical Monitoring
Chiltern International Ltd
2 Jahre und 1 Monat, Feb. 2013 - Feb. 2015
Director, Clinical Development
Innovare R&D
Clinical R&D in accordance to local and international regulatory landscape and business strategic needs Clinical Operations Project Management Pharmacoeconomic and Health Outcome Research studies Pharmacovigilance implementation BA/BE clinical strategy Healthcare Compliance implementation Therapeutic areas: Infectology (HIV), Hematology, Immunology and Intensive Care
1 Jahr, Jan. 2012 - Dez. 2012
Regional Clinical Trial Manager LATAM
Synthon
Strategic Project Management for BA/BE studies and international clinical trial in Mexico, Brazil and Chile. Therapeutic áreas: Multiple Sclerosis (Phase III: Bio-similar Product & Generic BE), Oncology (Phase III: Bio-similar & Generic BE), CNS (Generic BE), Cardiovascular (Generic BE), Urology (Generic BE).
3 Jahre, Jan. 2009 - Dez. 2011
Sr. Clinical Research Associate
ReSearch Pharmaceutical Services, Inc.
Site and Country feasibilities, Site Qualifications, Site Initiations, Site Monitoring Visits, Site Close-out Visits and Co-Monitoring Visits, performed on Phase I to III International Clinical Trials for the next therapeutic areas: Pediatric Vaccines, Pediatric Hematology (biotechnology product), Transplants- Nephrology, Rheumatology (biotechnology product), Orthopedics (biotechnology product), Pediatric T2DM, Hematology (biotechnology product) and Ophthalmology.
1 Jahr und 7 Monate, Juli 2007 - Jan. 2009
Clinical Research Site Manager
Global Clinical Operations Johnson & Johnson
Start up participation for an international phase III infectology (HIV) trial. Implementation, supervision and monitoring for international phase III psychiatry trial including SIV, SMV and SCOV. Implementation, supervision and monitoring for international phase IIb Metabolic trial, including SQV, Start-up, SIV, SMV and SCOV. Country and site feasibilities for an international phase III neuropathy trial.
2006 - 2006
Clinical Research Associate
Pfizer
Ausbildung von Daniel Maldonado
2015 - 2015
Biopharma Innovation
Rutgers University
2014 - 2014
Health Care Compliance
IPADE
2013 - 2013
Pharmacoeconomics
Universidad Nacional Autónoma de México
2012 - 2012
Bioequivalence
Universidad Nacional Autónoma de México
2010 - 2010
Clinical Research Project Management
IEEC - International Executive Education Center
2009 - 2020
Biotechnology Project Management
University of California, San Diego
Biotech Project Management Professional Certificate
2004 - 2006
Biochemistry
Universidad Nacional Autónoma de Mexico
Protein-protein interaction, Cell Signaling, Molecular Oncology
2001 - 2003
Molecular Biology
Georg August University of Göttingen
Biochemistry, Cell & Molecular Biology
1996 - 2000
Biology
Universidad Nacional Autónoma de México
Genomic Medicine and Environmental Toxicology
Sprachen
Englisch
Fließend
Spanisch
Muttersprache
Deutsch
Grundlagen